Life-Sustaining Treatment Ends Sooner for Uninsured Trauma Patients

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Aug. 2, 2024 -- Early withdrawal of life-sustaining therapy (WLST) is more likely among uninsured trauma patients, according to a study published online July 24 in JAMA Network Open.

Graeme Hoit, M.D., from the University of Toronto, and colleagues assessed if patient insurance type (private insurance, Medicaid, and uninsured) is associated with time to WLST in critically injured adults treated at U.S. trauma centers. The analysis included 307,731 patients injured between Jan. 1, 2017, and Dec. 31, 2020.

The researchers found that 4.2 percent of patients underwent WLST during their admission. Earlier WLST was significantly more likely among patients who were uninsured versus those with private insurance (hazard ratio, 1.54) and Medicaid (hazard ratio, 1.47). When excluding patients who died within 48 hours of presentation and after accounting for nonwithdrawal death as a competing risk, findings persisted.

"In this cohort study of U.S. adult trauma patients who were critically injured, patients who were uninsured underwent earlier WLST compared with those with private or Medicaid insurance," the authors write. "Based on our findings, a patient’s ability to pay was likely associated with a shift in decision-making for WLST, suggesting that socioeconomic status affects patient outcomes."

One author disclosed ties to the medical technology industry.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-08-03 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords